Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Experimental & Molecular Medicine ; : e234-2016.
Article Dans Anglais | WPRIM | ID: wpr-25936

Résumé

Peroxisome proliferator-activated receptor gamma (PPARγ) is a critical regulator of carbohydrate and lipid metabolism, adipocyte differentiation and inflammatory response. Post-translational modification of PPARγ and its degradation involve several pathways, including the ubiquitin–proteasome system. Here, we identified F-box only protein 9 (FBXO9) as an E3 ubiquitin ligase of PPARγ. We screened interacting partners of PPARγ using immunoprecipitation and mass spectrometric analysis and identified FBXO9 as an E3 ubiquitin ligase of PPARγ. FBXO9 directly interacted with PPARγ through the activation function-1 domain and ligand-binding domain. FBXO9 decreased the protein stability of PPARγ through induction of ubiquitination. We found that the F-box motif of FBXO9 was required for its ubiquitination function. The activity of PPARγ was significantly decreased by FBXO9 overexpression. Furthermore, FBXO9 overexpression in 3T3-L1 adipocytes resulted in decreased levels of endogenous PPARγ and suppression of adipogenesis. These results suggest that FBXO9 is an important enzyme that regulates the stability and activity of PPARγ through ubiquitination.


Sujets)
Adipocytes , Adipogenèse , Motifs F-box , Immunoprécipitation , Métabolisme lipidique , Récepteur PPAR gamma , Maturation post-traductionnelle des protéines , Stabilité protéique , Ubiquitine , Ubiquitin-protein ligases , Ubiquitination
2.
Diabetes & Metabolism Journal ; : 406-413, 2016.
Article Dans Anglais | WPRIM | ID: wpr-84888

Résumé

BACKGROUND: Panax ginseng has glucose-lowering effects, some of which are associated with the improvement in insulin resistance in skeletal muscle. Because mitochondria play a pivotal role in the insulin resistance of skeletal muscle, we investigated the effects of the ginsenoside Rg3, one of the active components of P. ginseng, on mitochondrial function and biogenesis in C2C12 myotubes. METHODS: C2C12 myotubes were treated with Rg3 for 24 hours. Insulin signaling pathway proteins were examined by Western blot. Cellular adenosine triphosphate (ATP) levels and the oxygen consumption rate were measured. The protein or mRNA levels of mitochondrial complexes were evaluated by Western blot and quantitative reverse transcription polymerase chain reaction analysis. RESULTS: Rg3 treatment to C2C12 cells activated the insulin signaling pathway proteins, insulin receptor substrate-1 and Akt. Rg3 increased ATP production and the oxygen consumption rate, suggesting improved mitochondrial function. Rg3 increased the expression of peroxisome proliferator-activated receptor γ coactivator 1α, nuclear respiratory factor 1, and mitochondrial transcription factor, which are transcription factors related to mitochondrial biogenesis. Subsequent increased expression of mitochondrial complex IV and V was also observed. CONCLUSION: Our results suggest that Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis, leading to an improvement in insulin resistance in skeletal muscle. Rg3 may have the potential to be developed as an anti-hyperglycemic agent.


Sujets)
Adénosine triphosphate , Technique de Western , Insuline , Substrats du récepteur à l'insuline , Insulinorésistance , Mitochondries , Fibres musculaires squelettiques , Muscles squelettiques , Facteur nucléaire-1 respiratoire , Biogenèse des organelles , Consommation d'oxygène , Panax , Péroxysomes , Réaction de polymérisation en chaîne , Transcription inverse , ARN messager , Facteurs de transcription
3.
Journal of Korean Medical Science ; : 644-652, 2012.
Article Dans Anglais | WPRIM | ID: wpr-202334

Résumé

Bisphenol A (BPA) has been reported to possess hepatic toxicity. We investigated the hypothesis that BPA, below the no observed adverse effect level (NOAEL), can induce hepatic damage and mitochondrial dysfunction by increasing oxidative stress in the liver. Two doses of BPA, 0.05 and 1.2 mg/kg body weight/day, were administered intraperitoneally for 5 days to mice. Both treatments impaired the structure of the hepatic mitochondria, although oxygen consumption rate and expression of the respiratory complex decreased only at the higher dose. The hepatic levels of malondialdehyde (MDA), a naturally occurring product of lipid peroxidation, increased, while the expression of glutathione peroxidase 3 (GPx3) decreased, after BPA treatment. The expression levels of proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) also increased. In HepG2 cells, 10 or 100 nM of BPA also decreased the oxygen consumption rate, ATP production, and the mitochondrial membrane potential. In conclusion, doses of BPA below the NOAEL induce mitochondrial dysfunction in the liver, and this is associated with an increase in oxidative stress and inflammation.


Sujets)
Animaux , Humains , Mâle , Souris , Adénosine triphosphate/métabolisme , Glutathione peroxidase/métabolisme , Cellules HepG2 , Inflammation/induit chimiquement , Injections péritoneales , Interleukine-6/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Foie/effets des médicaments et des substances chimiques , Malonaldéhyde/métabolisme , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Souris de lignée C57BL , Mitochondries/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Consommation d'oxygène/effets des médicaments et des substances chimiques , Phénols/toxicité , Facteur de nécrose tumorale alpha/métabolisme
SÉLECTION CITATIONS
Détails de la recherche